Literature DB >> 34022730

Construction of oxygen vacancy assisted Z-scheme BiO2-x/BiOBr heterojunction for LED light pollutants degradation and bacteria inactivation.

Jiawei Liu1, Liying Huang2, Yeping Li3, Lei Yang1, Chaobao Wang3, Juan Liu3, Yanhua Song4, Mengxin Yang1, Huaming Li5.   

Abstract

It is well known that the most important task of photocatalytic technology is to synthesize photocatalysts with compact heterojunction structure and high redox ability. To achieve the goal, a novel Z-scheme BiO2-x/BiOBr heterojunction containing oxygen vacancy was synthesized by an in-situ generation process. Several techniques, X-ray diffraction (XRD), transmission electron microscopy (TEM) and X-ray photoelectron spectroscopy (XPS) have verified the BiO2-x/BiOBr heterojunction. XPS and electron spin resonance (ESR) reveals the presence of oxygen vacancy in the BiO2-x/BiOBr composite. As expected, the BiO2-x/BiOBr composite showed good performance in removing Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), Rhodamine B (RhB) and tetracycline (TC). The effects of inorganic ions, pH value and water matrix were investigated with many details. The active species and proposed mechanism were revealed by trapping experiment and related characterizations. The synergistic effect of oxygen vacancy and Z-scheme heterojunction makes the BiO2-x/BiOBr composite possess excellent photocatalytic activity.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibacterial; BiO(2−x)/BiOBr; Oxygen vacancy; Photocatalytic degradation; Z-scheme

Year:  2021        PMID: 34022730     DOI: 10.1016/j.jcis.2021.04.143

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  1 in total

Review 1.  Modulation of Z-scheme photocatalysts for pharmaceuticals remediation and pathogen inactivation: Design devotion, concept examination, and developments.

Authors:  Mope Edwin Malefane; Potlako John Mafa; Thabo Thokozani Innocent Nkambule; Muthumuni Elizabeth Managa; Alex Tawanda Kuvarega
Journal:  Chem Eng J       Date:  2022-08-29       Impact factor: 16.744

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.